Literature DB >> 26411427

Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.

R Ramachandran1,2, P Doddi1,2, B Nandakrishna1,2, R Nada1,2, V Kumar1,2, M Rathi1,2, H S Kohli1,2, V Jha1,2, V Sakhuja1,2, K L Gupta3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26411427     DOI： 10.1007/s11255-015-1076-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  4 in total

1.  Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study.

Authors:  Jicheng Lv; Yihe Yang; Hong Zhang; Wenfang Chen; Xiaoxia Pan; Zhiling Guo; Caili Wang; Shen Li; Jianrong Zhang; Jianchun Zhang; Lijun Liu; Sufang Shi; Suxia Wang; Min Chen; Zhao Cui; Nan Chen; Xueqing Yu; Minghui Zhao; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

Review 2.  Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations.

Authors:  K K Jindal
Journal:  Kidney Int Suppl       Date:  1999-06       Impact factor: 10.545

3.  Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies.

Authors:  Lei-Shi Li; Zhi-Hong Liu
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

4.  Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.

Authors:  James A Tumlin; Verachai Lohavichan; Randy Hennigar
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992
  4 in total
  1 in total

1.  Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis.

Authors:  Bing Du; Ye Jia; Wenhua Zhou; Xu Min; Lining Miao; Wenpeng Cui
Journal:  BMC Nephrol       Date:  2017-07-19       Impact factor: 2.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.